drugset / Trial / NCT04703361
Effects of Ketones and Niacin in Heart Failure Patients
RandomizedCrossoverSingle-blindTreatment
Summary
Ketones, 3-hydroxybutyrate (3-OHB), have shown to have beneficial hemodynamics effect in patients with hearth failure with reduced ejection fraction. The mechanisms behind these marked hemodynamic effects are currently unknown, but could involve prostaglandin-release. 3-OHB is the endogenous ligand for the G protein-coupled receptor hydroxy-carboxylic acid 2 (HCA2) receptor. This receptor has proven downstream effects on cAMP and systemic effects via release of prostaglandins. In this present study we will investigate the cardiovascular effects of HCA2-receptor stimulation in heart failure patients.
Timeline
- Start
- 2021-02-15
- Primary completion
- 2021-09-03
- Completion
- 2021-09-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Na-3-OHB | Unknown | — | — |
| Subject | Niacin | Small molecule | — | — |